Page 12 - Dabur India

Market Ahead, May 27: All you need to know before the opening bell

Today, a total of 21 companies, including Dabur India, Sun Pharma, and United Spirits are scheduled to announce their results.

Lockdown 3.0: Rural India may drive demand recovery amid Covid-19 crisis

Top executives at auto, tractor and consumer packaged goods firms are optimistic. They are betting on the reverse migration of labourers boosting consumption and prediction of a favourable monsoon.

Dabur looks to sharpen its herbal edge as ayurvedic products get a push

As ayurvedic formulations get a renewed push in the fight against Covid-19, can one of the oldest players in the segment step up its game?

Covid-19 impact: Restrictions on movement still a pain point for FMCG firms

According to the Federation of West Bengal Truck Operators' Association (FWBTOA), truck availability has only improved marginally around 10 per cent of a total 9 million trucks in India.

Dabur, Himalaya witness spike in sales of Ayurvedic products amid Covid-19

For Himalaya, the surge in demand has been seen particularly in its Pure Herbs range such as Guduchi, Tulasi, Amalaki, Ashwagandha and others

Lockdown 2.0: India Inc lends help to dealers amid coronavirus crisis

Incentive hikes, credit period extension among steps taken to support them during corona crisis

Hindustan Unilever's valuation premium over peers hits record high

Trading at 77x, its trailing 12-month net profit against industry average of about 43x

Amul brings nostalgia back in ads to stay relevant amid Covid-19 lockdown

Leaning in on nostalgia and its long-standing relationship with customers, the legacy brand strives to be seen and heard amidst a lockdown

FMCG leaders mark down overall growth to 3% amid coronavirus outbreak

According to Nielsen, panic buying of food items and hygiene products has pushed up growth rates of food and non-food categories by 300 and 400 basis points respectively.

Weekly stock picks by Religare Broking: Buy Ajanta Pharma, Dabur India

Ajanta Pharma's stock has seen a fresh breakout from the trading range of roughly 1350-1480 levels

FMCG firms see slow demand revival as growth triggers remain weak

According to experts, discretio­nary businesses like food services and jewellery continue to have a greater presence in urban areas versus rural areas, where consumption slowdown has been pronounced.

FMCGs welcome Budget, says reduction in I-T slabs to drive consumption

Terming it as "incremental budget", Dabur India CEO Mohit Malhotra said the government continues to focus on farmers' income and is offering significant sops at the lower end of the spectrum

Dabur India surges 5% after Q3 result beats Street estimates

The management, however, said the near-term outlook for demand growth remains challenging with most key categories reporting a steady decline in value and volume growth.

Dabur's strategic moves pays well in Dec quarter, analysts remain positive

Topline up 7% led by 5.6% rise in volumes on faster rural sales, while pre-tax profit up over 9%

Dabur's growth potential justifies premium valuation of its stock

Focus on power brands and rural expansion augur well for the stock, trading at 43 times its FY21 estimated earnings

Consumption slowdown hits Dabur India profitability, PBT down 2.5% in Q2

The firm's PBT declined from Rs 473.7 crore last year to Rs 461.8 crore.

Amid one-off investment value impairment, Dabur Q2 net up 7% at Rs 404 cr

The net profit was impacted by one-time impairment in value of investments to the tune of Rs 40 crore

Dabur India stock gains 4%, nears record high post Q2 results

Consolidated net profit grew 7 per cent at Rs 403 crore as against Rs 377 crore in the year-ago quarter.

Technical calls by Religare Broking: Buy Dabur, HDFC, Hero Motocorp

Weekly Technical Recommendations by Religare Broking Ltd.

Multiple formats pave the pitch for Dabur's 30-year-old product Odomos

Dabur experiments with the packaging and the brand narrative of its Odomos; but can it do so without diluting the promise?